105 related articles for article (PubMed ID: 9004447)
1. Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine.
Ma J; Hine PM; Clough ER; Fish D; Coughlin RT; Beltz GA; Shew MG
Vaccine; 1996 Oct; 14(14):1366-74. PubMed ID: 9004447
[TBL] [Abstract][Full Text] [Related]
2. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
Coughlin RT; Fish D; Mather TN; Ma J; Pavia C; Bulger P
J Infect Dis; 1995 Apr; 171(4):1049-52. PubMed ID: 7706788
[TBL] [Abstract][Full Text] [Related]
3. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
Chang YF; Appel MJ; Jacobson RH; Shin SJ; Harpending P; Straubinger R; Patrican LA; Mohammed H; Summers BA
Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
[TBL] [Abstract][Full Text] [Related]
4. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.
Ma J; Bulger PA; Dante S; Davis DR; Perilli-Palmer B; Coughlin RT
J Infect Dis; 1995 Apr; 171(4):909-15. PubMed ID: 7706819
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi.
Conlon JA; Mather TN; Tanner P; Gallo G; Jacobson RH
Vet Ther; 2000; 1(2):96-107. PubMed ID: 19757556
[TBL] [Abstract][Full Text] [Related]
6. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.
Straubinger RK; Chang YF; Jacobson RH; Appel MJ
J Clin Microbiol; 1995 Oct; 33(10):2745-51. PubMed ID: 8567917
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
Chang Y; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH
Vaccine; 1999 Oct; 18(5-6):540-8. PubMed ID: 10519945
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM
Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
Grosenbaugh DA; Rissi DR; Krimer PM
Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
[TBL] [Abstract][Full Text] [Related]
10. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
[TBL] [Abstract][Full Text] [Related]
11. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
Eschner AK; Mugnai K
Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
[TBL] [Abstract][Full Text] [Related]
12. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.
Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB
Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763
[TBL] [Abstract][Full Text] [Related]
13. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.
Kalish RA; Leong JM; Steere AC
Infect Immun; 1993 Jul; 61(7):2774-9. PubMed ID: 7685738
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.
Edelman R; Palmer K; Russ KG; Secrest HP; Becker JA; Bodison SA; Perry JG; Sills AR; Barbour AG; Luke CJ; Hanson MS; Stover CK; Burlein JE; Bansal GP; Connor EM; Koenig S
Vaccine; 1999 Feb; 17(7-8):904-14. PubMed ID: 10067697
[TBL] [Abstract][Full Text] [Related]
15. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
Johnson BJ; Sviat SL; Happ CM; Dunn JJ; Frantz JC; Mayer LW; Piesman J
Vaccine; 1995 Aug; 13(12):1086-94. PubMed ID: 7491816
[TBL] [Abstract][Full Text] [Related]
16. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
Golde WT; Burkot TR; Piesman J; Dolan MC; Capiau C; Hauser P; Dequesne G; Lobet Y
Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis.
Magnarelli LA; Levy SA; Ijdo JW; Wu C; Padula SJ; Fikrig E
J Med Microbiol; 2001 Oct; 50(10):889-895. PubMed ID: 11599738
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
[TBL] [Abstract][Full Text] [Related]
19. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection.
Barthold SW; Levy SA; Fikrig E; Bockenstedt LK; Smith AL
J Am Vet Med Assoc; 1995 Dec; 207(11):1435-40. PubMed ID: 7493871
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.
Steere AC; Sikand VK; Meurice F; Parenti DL; Fikrig E; Schoen RT; Nowakowski J; Schmid CH; Laukamp S; Buscarino C; Krause DS
N Engl J Med; 1998 Jul; 339(4):209-15. PubMed ID: 9673298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
